BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20072888)

  • 1. Targeted magnetic liposomes loaded with doxorubicin.
    Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
    Methods Mol Biol; 2010; 605():279-93. PubMed ID: 20072888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
    Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
    J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Magnetic Liposomes Loaded with Doxorubicin.
    Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
    Methods Mol Biol; 2017; 1522():257-272. PubMed ID: 27837546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-bearing doxorubicin-loaded magnetic poly(N-isopropylacrylamide) microspheres as a new strategy for cancer therapy.
    Sun Y; Chen L; Yu J; Zhi X; Tang S; Zhou P; Wang C
    Anticancer Drugs; 2009 Aug; 20(7):607-15. PubMed ID: 19550294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
    Maeng JH; Lee DH; Jung KH; Bae YH; Park IS; Jeong S; Jeon YS; Shim CK; Kim W; Kim J; Lee J; Lee YM; Kim JH; Kim WH; Hong SS
    Biomaterials; 2010 Jun; 31(18):4995-5006. PubMed ID: 20347138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells.
    Asadishad B; Vossoughi M; Alamzadeh I
    Biotechnol Lett; 2010 May; 32(5):649-54. PubMed ID: 20131082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA].
    Zhang Q; Xiang GY; Long N; Lin JL; Zeng FB
    Yao Xue Xue Bao; 2005 Nov; 40(11):1046-50. PubMed ID: 16499093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
    Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
    Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
    Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
    Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery.
    Geers B; Lentacker I; Sanders NN; Demeester J; Meairs S; De Smedt SC
    J Control Release; 2011 Jun; 152(2):249-56. PubMed ID: 21362448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
    Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
    Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
    Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
    Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.